(8 months, 1 week ago)
Commons ChamberLike many hon. Members from across the House, I have cases of this kind in my constituency, and have been working to support the individuals involved. I reiterate the Government’s position, which is that I am sure the Secretary of State for Work and Pensions will want to update the House at the earliest occasion. He will clearly have to read the report and reflect on it, but I know that he is keen to do so swiftly.
This week, I had the privilege of meeting the inspirational Hannah Gardner, who has incurable secondary breast cancer at the age of just 37. Recently, Hannah and thousands of other women received the devastating news that the life-extending drug Enhertu, described by oncologists as a game-changer, has been rejected by the National Institute for Health and Care Excellence for use by the NHS in England, despite being approved in Scotland and 45 other countries worldwide. She brought a campaign to Parliament, because it is the only realistic treatment available for her, and time is not on her side. Can we have an urgent debate on getting all parties, including the drug companies, NICE and NHS England, back to the table, and urgently approving Enhertu, so that Hannah can at least realise her modest wish of seeing her three-year-old daughter Lilah attend her new school?
I thank my hon. Friend for all his campaigning in this area, and for all his work with a number of all-party parliamentary groups. I also thank him for arranging for me to meet Hannah when she visited Parliament. She is an inspirational woman, and the fact that she is campaigning so hard, not just for herself but for other people, is testament to that. I also thank the Breast Cancer Now team, who also visited me and are doing tremendous work in campaigning to ensure that not just Enhertu but other life-extending drugs can be approved.
I am sure that the Secretary of State for Health and Social Care will have heard about the campaign and will want to set up meetings to discuss it. I think that about 1,000 women a year in England could benefit from the drug, and given that it is widely available and deemed to be clinically and cost-effective elsewhere, I hope that NICE will reflect on that, and that a patient access scheme might be established. I will ensure that the Secretary of State has heard what my hon. Friend said.
(2 years, 5 months ago)
Commons ChamberOn 1 June, section 232 tariffs on imports of UK steel and aluminium products were lifted. We have also secured the lifting of the long-standing US ban on the import of British beef and lamb.
The Minister is doing excellent work to help pave the way for UK businesses to do more trade in the US, and lifting tariffs is just one of the ways we can do that. Will she set out what more the Government can do to support our leading service sectors, as well as help our small and medium-sized enterprises to get their foot in the door?
I thank my hon. Friend for raising that point. In addition to a free trade agreement, which will assist us on tariffs and those kinds of barriers, we are pursuing a twin-track approach with US states. That will help our service sector in particular. We are also looking at the mutual recognition of qualifications in accounting, auditing, legal services and so on. Next week, we are holding a UK-US SME dialogue in Boston to help us open up procurement possibilities for companies that would find it difficult to seek out those opportunities.
(5 years, 6 months ago)
Commons Chamber